Armata Pharmaceuticals(ARMP) - 2025 Q4 - Annual Results

Exhibit 99.1 Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results LOS ANGELES, California, March 25, 2026 - Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen- specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial results for its fourth quarter and full-year e ...